Orlando, FL. (PR) January 25, 2012
Capital Corp Merchant Banking has entered into a $ 135 million funding agreement with a leading American biotechnology company (The Client). The funds will be used to develop and commercialize the heavily patented technology that the Client has developed wherein a small molecular binder will be used to enable the active agent within various drugs to work effectively and without the side effects currently produced by the binding bacterial protein and current industry purification standard, Protein A.
Capital Corp Merchant Banking offers quality Merchant Banking services for a variety of projects worldwide. Capital Corp Merchant Banking has developed close working relationships with groups of Professionals: Specialists in Finance, Commercial Risks Insurance and Re-Insurance, International Accounting Firms and Law Firms, and the largest Valuation Firm in the world. Capital Corp Merchant Banking is solution-oriented and known for being the most flexible Funding Source on the Market in creating handcrafted investment structures to meet the needs of the different constituent groups in each individual transaction. Capital Corp Merchant Banking offers many services: Project Financing, Consulting, Due Diligence, Evaluation of a Business, Negotiating Services, Acquisitions, Investment Approach, and Presentation Reports as well.
The funds will also be used to build a production facility in Germany so as to be able to address not only the U.S. but European market as well. The facility will also have an R&D section where the Client plans to develop other small molecule binders in time. The Client plans to acquire no less than 10% of the Protein A market worldwide by Phase III. Total project costs will amount to USD $ 150 million.
The method by which this project is to be funded is the brainchild of Mr Gilles Herard, Jr. Mr Herard is a seasoned Merchant Banker and has been in the banking industry for 38 years. He worked early in his career at the Toronto Dominion Bank (Canada) and later on joined Manufacturer Hanover (MH) of New York as Senior Credit Analyst. He eventually created his own Firm, Capital Corp Merchant Banking, where he syndicates and structures funding for top companies worldwide, all the while investing his own firms funds into the projects.
As the head of Capital Corp Merchant Banking, Mr Herard has become a leading figure in international middle-market project financing and engineers all funding structures for projects at Capital Corp. Mr Herard has received numerous awards for his work and other contributions including being appointed to the Presidential Business Commission, Honorary Co-Chairman of the Business Advisory Council, nominated as Executive of the Year by the internationally acclaimed National Registers Whos Who, and having received the Senatorial Medal of Freedom, among many others.
Related Toronto Business News